Mary Windham, MD
Endocrinology, Diabetes & Metabolism · Branford, CTNPI 1417485830
Payments from drug & device makers
Across 67 payments — averaging $28.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$406
- Ascendis Pharma Endocrinology Inc$264
- Lilly USA, LLC$126
- Abbott$115
- Boehringer Ingelheim$106
- Insulet Corporation$97
- plus $814 from 21 others
What the payments were for
- Food & beverage$1,928100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $406 |
| Ascendis Pharma Endocrinology Inc | 8 | $264 |
| Lilly USA, LLC | 6 | $126 |
| Abbott | 5 | $115 |
| Boehringer Ingelheim | 4 | $106 |
| Insulet Corporation | 4 | $97 |
| Radius Health, Inc. | 3 | $96 |
| Chiesi USA, Inc. | 3 | $80 |
| Novo Nordisk | 3 | $76 |
| Mannkind Corporation | 2 | $75 |
| Tandem Diabetes Care, Inc. | 1 | $52 |
| Sequel Med Tech, LLC | 2 | $47 |
| Kyowa Kirin, Inc. | 2 | $41 |
| Medtronic | 2 | $39 |
| AstraZeneca | 1 | $34 |
| Recordati_rare_diseases_inc. | 1 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| BETA Bionics, Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $24 |
| Sandoz | 1 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Novartis | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$254
How this compares
$1,928 in reported general payments places this provider in the 60th percentile of 177 endocrinology, diabetes & metabolism providers in Connecticut.
See all endocrinology, diabetes & metabolism providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $132 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Branford
- Reza YavariBranford$9K
- Jean HenryBranford$7K
- Ania JastreboffNew Haven$2.2M
- Ilja HulinskyBridgeport$1.6M
- Gerald ShulmanNew Haven$1M
- Karl InsognaNew Haven$903K
- Clemens BergwitzNew Haven$735K
- Egils BogdanovicsTorrington$608K
- Robert ObersteinHartford$516K
- Fadi Al-KhayerStorrs$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.